Aclaris Therapeutics Reports First Quarter 2023 Financial Results, Provides Corporate Update - MyChesCo
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced its financial results for the first quarter of 2023 and provided a corporate update. “The first quarter of 2023 …
MyChesCo
